Teleflex Incorporated (NYSE:TFX) Short Interest Down 37.1% in April

Teleflex Incorporated (NYSE:TFX) saw a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 1,560,000 shares, a decrease of 37.1% from the March 31st total of 2,480,000 shares. Based on an average daily volume of 1,140,000 shares, the days-to-cover ratio is currently 1.4 days. Approximately 3.5% of the shares of the company are short sold.

Teleflex Stock Down 0.4 %

Shares of NYSE TFX opened at $134.69 on Tuesday. Teleflex has a 12-month low of $124.66 and a 12-month high of $249.91. The stock has a market cap of $6.25 billion, a PE ratio of 26.78, a P/E/G ratio of 1.73 and a beta of 1.19. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average of $139.36 and a 200 day moving average of $172.78.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. As a group, sell-side analysts predict that Teleflex will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 1.01%. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Institutional Trading of Teleflex

Hedge funds have recently made changes to their positions in the company. Barclays PLC increased its holdings in Teleflex by 1.6% in the 3rd quarter. Barclays PLC now owns 89,907 shares of the medical technology company’s stock valued at $22,233,000 after purchasing an additional 1,426 shares during the last quarter. Wilmington Savings Fund Society FSB grew its stake in shares of Teleflex by 6.3% in the third quarter. Wilmington Savings Fund Society FSB now owns 27,759 shares of the medical technology company’s stock valued at $6,865,000 after buying an additional 1,647 shares in the last quarter. Tidal Investments LLC raised its holdings in shares of Teleflex by 29.7% in the 3rd quarter. Tidal Investments LLC now owns 8,014 shares of the medical technology company’s stock valued at $1,982,000 after buying an additional 1,837 shares during the period. Franklin Resources Inc. raised its holdings in shares of Teleflex by 64.3% in the 3rd quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company’s stock valued at $2,298,000 after buying an additional 3,790 shares during the period. Finally, American Trust purchased a new stake in shares of Teleflex in the 3rd quarter valued at $212,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Truist Financial decreased their price objective on shares of Teleflex from $149.00 to $140.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Mizuho set a $155.00 price objective on shares of Teleflex in a research report on Wednesday, April 16th. Wells Fargo & Company decreased their price objective on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Finally, Morgan Stanley decreased their price objective on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research report on Wednesday, March 5th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $169.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.